Federal health agencies issue narrowed COVID-19 vaccine recommendations, creating insurance coverage uncertainty for fall 2025 vaccines amid evolving approval criteria and risk-based eligibility.

Increasing specialty drug costs lead to greater use of alternative funding programs in employer health plans, raising access and cost concerns amid rising drug prices.

Explore 2025 legislative changes impacting employer-sponsored health plans, including telehealth coverage, gender-affirming care, PBM regulations, and HSA rules. Key insights for plan sponsors and insurers.